LTZ Therapeutics
Develops immunotherapies to harness myeloid biology for cancer treatment
$38MUndisclosed
Role not disclosedLoading investors…
Activity from announced rounds
Develops immunotherapies to harness myeloid biology for cancer treatment
Develops intelligent platform-driven macrocyclic peptide drug discovery
Helps teams build deploy and operate production-grade AI applications and agentic workflows
Provides modular and prefabricated data center infrastructure